Capecitabine Mylan 500 mg Filmdragerad tablett

Maa: Ruotsi

Kieli: ruotsi

Lähde: Läkemedelsverket (Medical Products Agency)

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
20-04-2018
Valmisteyhteenveto Valmisteyhteenveto (SPC)
20-04-2018

Aktiivinen ainesosa:

kapecitabin

Saatavilla:

Mylan S.A.S.

ATC-koodi:

L01BC06

INN (Kansainvälinen yleisnimi):

capecitabine

Annos:

500 mg

Lääkemuoto:

Filmdragerad tablett

Koostumus:

kapecitabin 500 mg Aktiv substans

luokka:

Apotek

Prescription tyyppi:

Receptbelagt

Terapeuttinen alue:

Kapecitabin

Valtuutuksen tilan:

Avregistrerad

Valtuutus päivämäärä:

2012-11-16

Pakkausseloste

                                PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CAPECITABINE MYLAN 150 MG FILM-COATED TABLETS
CAPECITABINE MYLAN 500 MG FILM-COATED TABLETS
capecitabine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Capecitabine Mylan is and what it is used for
2.
What you need to know before you take Capecitabine Mylan
3.
How to take Capecitabine Mylan
4.
Possible side effects
5.
How to store Capecitabine Mylan
6.
Contents of the pack and other information
1.
WHAT CAPECITABINE MYLAN IS AND WHAT IT IS USED FOR
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 150 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan belongs to the group of medicines called
"cytostatic medicines", which stop the
growth of cancer cells. Capecitabine Mylan contains 500 mg
capecitabine, which itself is not a
cytostatic medicine. Only after being absorbed by the body is it
changed into an active anti-cancer
medicine (more in tumour tissue than in normal tissue).
Capecitabine Mylan is used in the treatment of colon, rectal, gastric,
or breast cancers.
Furthermore, Capecitabine Mylan is used to prevent new occurrence of
colon cancer after complete
removal of the tumour by surgery.
Capecitabine Mylan may be used either alone or in combination with
other medicines.
2.
WHAT Y
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste englanti 02-06-2015
Valmisteyhteenveto Valmisteyhteenveto englanti 22-10-2014
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta englanti 28-01-2013